Our Mission:
We strive for
excellence in helping those presenting with IBS after diagnoses, to have access
to current and accurate IBS information and news. We also offer information on
the
IBS Audio Program 100 ™
a safe, highly effective and tested treatment option for IBS sufferers which can
be used in the comfort of one's
home. This enables the IBS sufferer to help themselves and their symptoms.
It is also very important to dispel
any myths between stage hypnosis and specific clinical hypnotherapy for the
treatment of IBS.
The IBS Audio Program 100 ™
Clinical Gut-Specific or Gut-Directed Hypnotherapy are
hypnotherapy methods with over 20 years of solid scientific research in IBS.
They are methods used today in general practice and have been used to alleviate
all associated or global symptoms of IBS, pain, bloating, gas, diarrhea,
constipation, alternating diarrhea and constipation and many other symptoms
associated with IBS including non GI symptoms, generally found among IBS
patients.
Michael Mahoney is one of the United Kingdom's leading clinical
Hypnotherapist in this field with professional experience since 1986. His
services are regularly used by gastroenterologists, doctors and other medical
professionals. Michael is an associate member of the Primary Care Society for
Gastroenterology.
This website will supply you with information and research into the use of
hypnotherapy for the treatment of Irritable Bowel Syndrome and the symptoms
associated with this condition. Mr. Mahoney's professional attitude, references
and years of clinical experience in the field of IBS has enabled him a unique
view into the condition and the development of The IBS Audio Program 100 ™. The
program is a highly cost effective, complementary home treatment for the
alleviation of all variations of IBS symptoms.
The first thing is to learn about hypnosis itself, but also to learn about
hypnosis for IBS. It has been researched clinically in IBS for over twenty years
and has shown to be an effective and safe treatment for the majority of those
diagnosed with IBS.
Whether you are an IBS sufferer seeking relief and IBS treatment information, or
a medical professional, this irritable bowel syndrome information will be most
helpful to you or your patients in obtaining extensive improvement for the
condition.
In the UK and US, irritable bowel syndrome research shows that Clinical
Hypnotherapy has been used successfully for IBS treatment and its improvement
for many years. Through the IBS Audio Program 100®, this IBS treatment method
has been further clinically trialed, researched and developed and made available
to IBS sufferers not only in the UK, but worldwide. It has since been used in
over 30 countries
Developed by UK Clinical Hypnotherapist, Michael Mahoney, using a 'gut-specific'
technique called OPSIM™ (On-going Progressive Session Induction Method™), the
IBS Audio Program 100® is safe, has no side effects, and can be used alone, or
in conjunction with conventional IBS treatment methods such as medication. And
while IBS medications such as antispasmodics, etc. may be taken while doing the
program, most program listeners have found such relief that the need for
medications in most cases have been greatly reduced or even eliminated
altogether. Further, it may be noted, that the initial successful clinical
trials were completed with those patients diagnosed as having refractory IBS,
that is, IBS cases so severe, that all other IBS therapy and medical
interventions had failed.
This IBS treatment method has been used successfully with thousands of IBS
patients, who have been able to not only reduce their irritable bowel syndrome
symptoms, but through this IBS therapy, patients were also able to break the
mind-gut connection of anxiety and worry about bowel "accidents" and
embarrassment.
To learn more about irritable bowel syndrome information from the UK, the
IBS
Audio Program 100® as a successful IBS therapy treatment method, its author, and
how it can help you or your IBS patients, please browse this site. And thank you
for visiting!
Dig Dis Sci. 2009 Apr 1.
A Focus Group Assessment of Patient Perspectives on Irritable Bowel Syndrome
and Illness Severity.
Drossman DA, Chang L, Schneck S, Blackman C, Norton WF, Norton NJ.
UNC Center for Functional GI and Motility Disorders, Division of
Gastroenterology and Hepatology, University of North Carolina, 4150
Bioinformatics Building CB#7080, Chapel Hill, NC, 27599-7080, USA, Drossman@med.unc.edu.
There is a growing need to understand from the patient's perspective the
experience of irritable bowel syndrome (IBS) and the factors contributing to its
severity; this has been endorsed by the Food and Drug Administration (FDA).
Accordingly, we conducted focus groups to address this issue. A total of 32
patients with mostly moderate to severe IBS were recruited through advertising
and were allocated into three focus groups based on predominant stool pattern.
The focus groups were held using standard methodology to obtain a general
assessment of the symptoms experienced with IBS, its impact, and of factors
associated with self-perceived severity. Patients described IBS not only as
symptoms (predominantly abdominal pain) but mainly as it affects daily function,
thoughts, feelings and behaviors. Common responses included uncertainty and
unpredictability with loss of freedom, spontaneity and social contacts, as well
as feelings of fearfulness, shame, and embarrassment. This could lead to
behavioral responses including avoidance of activities and many adaptations in
routine in an effort for patients to gain control. A predominant theme was a
sense of stigma experienced because of a lack of understanding by family,
friends and physicians of the effects of IBS on the individual, or the
legitimacy of the individual's emotions and adaptation behaviors experienced.
This was a barrier to normal functioning that could be ameliorated through
identifying with others who could understand this situation. Severity was linked
to health-related quality of life (HRQOL) and was influenced by the intensity of
abdominal pain and other symptoms, interference with and restrictions relating
to eating, work, and social activities, and of the unpredictability of the
condition. This study confirms the heterogeneous and multi-component nature of
IBS. These qualitative data can be used in developing health status and severity
instruments for larger-scale studies.
PMID: 19337833
-
